Gsk (GSK) Price to Sales (2009 - 2026)
Gsk's (GSK) Price to Sales was 1.35 for the quarter ended Sep 30, 2026, down 38.9% from 2.21 a year earlier and down 8.6% from the prior quarter.
Powered by 
Analysis
Gsk (GSK) Price to Sales (2009 - 2026) Analysis & Trends
For the year ended Dec 31, 2025, Price to Sales at Gsk was 2.46, up 35.1% from the prior year.
- By year, Price to Sales came in at 1.82 in the year ended Dec 31, 2024 (-14.1%), 2.12 in the year ended Dec 31, 2023 (+1.5%), 2.09 in the year ended Dec 31, 2022 (-25.4%) and 2.80 in the year ended Dec 31, 2021 (+10.3%).
- The figure for the quarter ended Sep 30, 2026 ranks as the lowest quarterly Price to Sales in data going back to the quarter ended Mar 31, 2009.
- Year over year, Price to Sales has now declined in each of the last eight quarters, with an average decline of 18.0% over the last eight quarters.
- The high point for year-over-year Price to Sales in five years was the quarter ended Dec 31, 2021 (growth of 54.7%); the low point was the quarter ended Sep 30, 2026 (a decline of 38.9%).
- Per Business Quant data, the three quarters before the quarter ended Sep 30, 2026 came in at 1.48 (quarter ended Jun 30, 2026), 1.57 (quarter ended Mar 31, 2026) and 1.41 (quarter ended Dec 31, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,224.11 Bn | 1,197.72 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 665.34 Bn | 585.20 Bn | 17.30 Bn |
| 3 | AbbVie | 515.72 Bn | 483.73 Bn | 13.12 Bn |
| 4 | Merck | 362.64 Bn | 325.58 Bn | 13.19 Bn |
| 5 | Novartis Ag | 315.51 Bn | 288.75 Bn | - |
| 6 | Astrazeneca | 289.26 Bn | 263.15 Bn | 13.26 Bn |
| 7 | Amgen | 249.20 Bn | 200.85 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 207.48 Bn | 182.59 Bn | 6.73 Bn |
| 9 | Pfizer | 167.49 Bn | 114.85 Bn | 12.56 Bn |
| 10 | Gsk | 102.08 Bn | 84.92 Bn | 8.73 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 1.35 |
| Jun 30, 2026 | 1.48 |
| Mar 31, 2026 | 1.57 |
| Dec 31, 2025 | 1.41 |
| Sep 30, 2025 | 2.21 |
| Jun 30, 2025 | 2.02 |
| Mar 31, 2025 | 2.08 |
| Dec 31, 2024 | 1.82 |
| Sep 30, 2024 | 2.22 |
| Jun 30, 2024 | 2.10 |
| Mar 31, 2024 | 2.39 |
| Dec 31, 2023 | 2.12 |
| Sep 30, 2023 | 2.15 |
| Jun 30, 2023 | 2.18 |
| Mar 31, 2023 | 2.19 |
| Dec 31, 2022 | 2.09 |
| Sep 30, 2022 | 1.71 |
| Jun 30, 2022 | 2.53 |
| Mar 31, 2022 | 2.57 |
| Dec 31, 2021 | 2.80 |
API Access
Gsk Price to Sales API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=price-to-sales&ticker=GSK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "price-to-sales", "ticker": "GSK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=price-to-sales&ticker=GSK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();